Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss

被引:18
|
作者
Sevil, Ergun [1 ]
Bercin, Sami [2 ]
Muderris, Togay [3 ]
Gul, Fatih [3 ]
Kiris, Muzaffer [2 ]
机构
[1] Karaman State Hosp, Dept Otorhinolaryngol Head & Neck Surg, TR-70100 Karaman, Turkey
[2] Yildirim Beyazit Univ, Dept Otorhinolaryngol Head & Neck Surg, Fac Med, Ankara, Turkey
[3] Ataturk Training & Res Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ankara, Turkey
关键词
Idiopathic sudden sensorineural hearing loss; Hyperbaric oxygen; Steroid; INTRATYMPANIC DEXAMETHASONE; SYSTEMIC THERAPY; DOUBLE-BLIND; EFFICACY; FAILURE;
D O I
10.1007/s00405-015-3791-6
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The purpose of the study was to assess the efficacy of the association of intratympanic (IT) steroid and hyperbaric oxygen (HBO) therapy in patients presenting with idiopathic sudden sensorineural hearing loss (ISSNHL), and to compare this protocol with another consisting of intravenous (IV) steroid administration and HBO therapy. A total of 80 patients diagnosed with ISSNHL were included in this prospective trial. Patients were divided into three categories: a mild-to-moderate ISSNHL group with a pure-tone average (PTA) aecurrency sign60 decibels (dB), a severe ISSNHL group with a PTA of 60-80 dB, and a profound ISSNHL group with a PTA aeyen81 dB. The first protocol consisted of 20 sessions of HBO therapy together with IV methylprednisolone 1 mg/kg body weight and a 10 mg taper every 3 days for 10 days. The second protocol consisted of HBO therapy for 20 sessions, together with an IT injection of dexamethasone at a dose of 4 mg/mL, 0.5-0.7 mL once a day for 7 consecutive days, performed 3 h before the HBO therapy. In the mild-to-moderate ISSNHL patients, the mean hearing gain and successful treatment rate was 19 (0-27) dB and 78.9 %, respectively in the IT + HBO treatment group, and 18 (3-44) dB and 70.5 % in the IV + HBO therapy group. In the severe ISSNHL patients, the mean hearing gain and successful treatment rate was 33 (1-54) dB and 81.8 %, respectively in the IT + HBO treatment group and 33.5 (7-57) dB and 58.2 % in the IV + HBO group. In the profound ISSNHL patients, the mean hearing gain and successful treatment rate was 36 (4-69) dB and 40 %, respectively in the IT + HBO therapy group, and 39.5 (0-92) dB and 72.7 % in the IV + HBO treatment group. The results demonstrated that patients with severe hearing loss success rate was superior in the group submitted to IT + HBO treatment, conversely IV + HBO therapy may be benefit for patients with profound hearing loss. Nevertheless, these clinical results were not statistically significant.
引用
收藏
页码:2419 / 2426
页数:8
相关论文
共 50 条
  • [1] Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss
    Ergun Sevil
    Sami Bercin
    Togay Muderris
    Fatih Gul
    Muzaffer Kiris
    [J]. European Archives of Oto-Rhino-Laryngology, 2016, 273 : 2419 - 2426
  • [2] Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases
    Yalcin Alimoglu
    Ender Inci
    Deniz Tuna Edizer
    Alper Ozdilek
    Mehmet Aslan
    [J]. European Archives of Oto-Rhino-Laryngology, 2011, 268 : 1735 - 1741
  • [3] Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss
    Takeyuki Fujimura
    Hideaki Suzuki
    Teruo Shiomori
    Tsuyoshi Udaka
    Takanori Mori
    [J]. European Archives of Oto-Rhino-Laryngology, 2007, 264 : 861 - 866
  • [4] Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss
    Fujimura, Takeyuki
    Suzuki, Hideaki
    Shiomori, Teruo
    Udaka, Tsuyoshi
    Mori, Takanori
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (08) : 861 - 866
  • [5] Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid plus hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases
    Alimoglu, Yalcin
    Inci, Ender
    Edizer, Deniz Tuna
    Ozdilek, Alper
    Aslan, Mehmet
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (12) : 1735 - 1741
  • [6] Hyperbaric Oxygen Therapy as Concurrent Treatment with Systemic Steroids for Idiopathic Sudden Sensorineural Hearing Loss: A Comparison of Three Different Steroid Treatments
    Hosokawa, Seiji
    Hosokawa, Kumiko
    Takahashi, Goro
    Sugiyama, Ken-ichi
    Nakanishi, Hiroshi
    Takebayashi, Satoru
    Mineta, Hiroyuki
    [J]. AUDIOLOGY AND NEURO-OTOLOGY, 2018, 23 (03) : 145 - 151
  • [7] Comparison of Steroid Treatment with and without Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss
    Yucel, Abitter
    Ozbugday, Yasar
    [J]. JOURNAL OF AUDIOLOGY AND OTOLOGY, 2020, 24 (03): : 127 - 132
  • [8] Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy
    Suzuki, Hideaki
    Hashida, Koichi
    Khac-Hung Nguyen
    Hohchi, Nobusuke
    Katoh, Akiko
    Koizumi, Hiroki
    Ohbuchi, Toyoaki
    [J]. LARYNGOSCOPE, 2012, 122 (05): : 1154 - 1157
  • [9] Comparison of simultaneous systemic steroid and hyperbaric oxygen treatment versus only steroid in idiopathic sudden sensorineural hearing loss
    Callioglu, Elif Ersoy
    ArzuTuzuner
    Demirci, Sule
    Cengiz, Ceyhun
    Caylan, Refik
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9876 - 9882
  • [10] Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
    Bennett, Michael H.
    Kertesz, Tom
    Perleth, Matthias
    Yeung, Philip
    Lehm, Jan P.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):